跳至主要内容
临床试验/EUCTR2017-001788-19-AT
EUCTR2017-001788-19-AT进行中(未招募)1 期

Metformin therapy to prohibit progression in patients with abdominal aortic aneurysm - METAAA Study

Medical University Vienna0 个研究点目标入组 170 人开始时间: 2018年8月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Infrarenal AAA of 3-4.9 cm maximum diameter
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 170
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 170

排除标准

  • premenopausal female patients with a pregnancy possibility
  • patients with diabetes
  • indication for surgical AAA repair
  • life expectancy <2 years
  • contraindications for metformin, i.e. severly reduced kidney
  • function (eGFR <30 ml/min), liver dysfunction, pancreatitis,
  • alcohol abusus, malnutrition and decompensated heart failure

研究者

发起方
Medical University Vienna

相似试验